1. Home
  2. KRYS vs CIGI Comparison

KRYS vs CIGI Comparison

Compare KRYS & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$241.84

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo Colliers International Group Inc. Subordinate Voting Shares

CIGI

Colliers International Group Inc. Subordinate Voting Shares

HOLD

Current Price

$146.57

Market Cap

7.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
CIGI
Founded
2015
1972
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
7.3B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
KRYS
CIGI
Price
$241.84
$146.57
Analyst Decision
Strong Buy
Buy
Analyst Count
9
7
Target Price
$214.22
$175.00
AVG Volume (30 Days)
286.6K
124.9K
Earning Date
11-03-2025
11-04-2025
Dividend Yield
N/A
0.21%
EPS Growth
275.72
N/A
EPS
6.66
2.30
Revenue
$373,164,000.00
$5,453,534,000.00
Revenue This Year
$36.14
$17.67
Revenue Next Year
$41.80
$7.35
P/E Ratio
$36.72
$63.26
Revenue Growth
54.51
19.71
52 Week Low
$122.80
$100.86
52 Week High
$248.60
$171.51

Technical Indicators

Market Signals
Indicator
KRYS
CIGI
Relative Strength Index (RSI) 74.92 51.74
Support Level $213.83 $142.99
Resistance Level $248.60 $147.18
Average True Range (ATR) 7.44 3.09
MACD 1.29 0.96
Stochastic Oscillator 78.92 91.83

Price Performance

Historical Comparison
KRYS
CIGI

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About CIGI Colliers International Group Inc. Subordinate Voting Shares

Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.

Share on Social Networks: